Henry TD, Schaer GL, DeMaria A, Recker D, Remmers AE, Goodrich J, Patel A. The iXCELL-DCM Trial: Rationale and Design. Cell Transplant. 2016 Mar 22. [Epub ahead of print]. DOI:10.3727/096368916X691295.
Pei S, Minhajuddin M, Callahan KP, et al. Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells. JBC Papers in Press. Published on October 2, 2013 as Manuscript M113.511170 doi: 10.1074/jbc.M113.511170.